Calithera Biosciences Stock Price (NASDAQ:CALA)

Add to My Stocks
$4.8 $0.12 (2.56%) CALA stock closing price Sep 17, 2018 (Closing)
Prev Close* : $4.68
Market Cap:
$168.24M
Day Low: $4.6
52 Week Low: $4.05
Open: $4.7
Volume: -
Day High: $4.8
52 Week High: $18.35
Dividend:
0.00

Latest Stock Market News

Latest Articles

Calithera Biosciences News - From Partners

CALA Stockcharts

View CALA PE ratio, PS ratio stocks charts and compare with peers.
CALA Chart
Note: Compare Calithera Biosciences stock price history with the index and industry peers.

Calithera Biosciences Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
4.68
PB ratio (
price to book ratio
)
1.12

Calithera Biosciences Returns

ROE
(return on equity)
-22%

Calithera Biosciences Financial Ratios

Asset Turnover
0.41
Receivables Turnover
18.49
Debt to Equity
0
Dividend Yield
0%

CALA Industry Peers

Company Price Change (%)
Mediwound (MDWD)6.450.05 (0.77%)
Recro Pharma (REPH)7.70.86 (10.05%)
Pfizer (PFE)43.010.05 (0.12%)
Bristol-myers Squibb (BMY)61.30.61 (1.01%)
Merck (MRK)70.420.44 (0.63%)
Tg Therapeutics (TGTX)9.51.25 (11.63%)
Fortress Biotech (FBIO)1.60.03 (1.91%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Neptune Tech. & Bio. (NEPT)4.210.39 (10.21%)
Rigel Pharma (RIGL)3.410.2 (6.23%)
Galectin Therapeutics (GALT)5.740.32 (5.9%)
Ionis Pharma (IONS)48.192.19 (4.76%)
Spectrum Pharma (SPPI)20.130.55 (2.81%)
Corcept Therapeutics (CORT)14.740.35 (2.43%)
Grifols (GRFS)20.420.35 (1.74%)
Top gainers from Medical-Drugs industry
* As of Sep 18, 2018
CompanyPriceChange (%)
Recro Pharma (REPH)7.70.86 (10.05%)
CASI Pharma (CASI)5.630.59 (9.49%)
Achaogen (AKAO)4.110.36 (8.05%)
ArQule (ARQL)5.040.43 (7.86%)
CORREVIO PHARMA (CORV)4.30.33 (7.13%)
Ironwood Pharma (IRWD)17.091.18 (6.46%)
Aerie Pharma (AERI)56.153 (5.07%)
Top losers from Medical-Drugs industry
* As of Sep 18, 2018

Calithera Biosciences Inc Stock News - Partner Headlines

Calithera Biosciences Financial Statements

income statement20172016201520142013
Net Sales or Revenues25.95M----
Net Income-27.82M-38M-32.64M-21.71M-12.37M
Total Operating Expense55.64M38.32M32.81M21.71M12.37M
View Calithera Biosciences income statement
balance sheet20172016201520142013
Total Assets192.45M54.79M75.75M104.77M34.84M
Total Liabilities42.14M4.89M3.96M4.4M1.37M
Shareholders Equity150.3M49.9M71.78M100.36M33.46M
View Calithera Biosciences balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities35.22M1.84M-1.4M1.42M-
Net Cash from (used by) Operating Activities13.75M-31.02M-29.93M-19.23M-11.83M
Increase (Decrease) in Prop Plant And Equipment-1.22M-0.4M-0.44M-0.55M-0.16M
View Calithera Biosciences cash flow statement

Calithera Biosciences Stock Message Board

Calithera Biosciences stock gained 2.56%, and the last close price as of Sep 17, 2018 is $4.8 for CALA stock. Calithera Biosciences market capitalization is $168.24M and it represents the total market value of CALA stock. Calithera Biosciences valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

Demand for a stock decides its stock market price. For example, if more investors want to buy CALA stock than sell it, then Calithera Biosciences stock price goes up. Conversely, if more investors wanted to sell CALA stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume number in Calithera Biosciences stock quote data shows the number of shares traded. For Ex: 399,050 Calithera Biosciences shares were traded as of last trading day, as seen from Calithera Biosciences stock chart. Calithera Biosciences paid 0.00 stock dividends to its shareholders during last quarter. Calithera Biosciences stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.